FDA MedWatch Safety AlertsUnited States14 October 2026
Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
This is an official announcement record
Firsthand records what FDA MedWatch Safety Alerts announced and links to the original. The wording below is theirs, not ours.
FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 13, 2026 – Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level. This recall is being conducted due to the presence of particulate matter, identified as cellulose, polystyrene, polyethylene terepht
Read the official announcement
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
- Convenience Kit Recall: AVID Medical Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall14 October 2026
- Convenience Kit Recall: Medline Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall13 October 2026
- Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter9 October 2026
- Early Alert: Diagnostic Ultrasound System Issue from Philips Ultrasound9 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.